These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27461566)

  • 21. Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario.
    Altaner C; Altanerova V; Cihova M; Ondicova K; Rychly B; Baciak L; Mravec B
    Int J Cancer; 2014 Mar; 134(6):1458-65. PubMed ID: 24038033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.
    Kosaka H; Ichikawa T; Kurozumi K; Kambara H; Inoue S; Maruo T; Nakamura K; Hamada H; Date I
    Cancer Gene Ther; 2012 Aug; 19(8):572-8. PubMed ID: 22744211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Adachi Y; Tamiya T; Ichikawa T; Terada K; Ono Y; Matsumoto K; Furuta T; Hamada H; Ohmoto T
    Hum Gene Ther; 2000 Jan; 11(1):77-89. PubMed ID: 10646641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia imaging predicts success of hypoxia-induced cytosine deaminase/5-fluorocytosine gene therapy in a murine lung tumor model.
    Lee BF; Lee CH; Chiu NT; Hsia CC; Shen LH; Shiau AL
    Cancer Gene Ther; 2012 Apr; 19(4):255-62. PubMed ID: 22281757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases.
    Matuskova M; Kozovska Z; Toro L; Durinikova E; Tyciakova S; Cierna Z; Bohovic R; Kucerova L
    J Exp Clin Cancer Res; 2015 Apr; 34(1):33. PubMed ID: 25884597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice.
    Khatri A; Zhang B; Doherty E; Chapman J; Ow K; Pwint H; Martiniello-Wilks R; Russell PJ
    J Gene Med; 2006 Sep; 8(9):1086-96. PubMed ID: 16832832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Tumor Effects of MAPK-Dependent Tumor-Selective Oncolytic Vaccinia Virus Armed with CD/UPRT against Pancreatic Ductal Adenocarcinoma in Mice.
    Kurosaki H; Nakatake M; Sakamoto T; Kuwano N; Yamane M; Ishii K; Fujiwara Y; Nakamura T
    Cells; 2021 Apr; 10(5):. PubMed ID: 33922406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system.
    Miyagi T; Koshida K; Hori O; Konaka H; Katoh H; Kitagawa Y; Mizokami A; Egawa M; Ogawa S; Hamada H; Namiki M
    J Gene Med; 2003 Jan; 5(1):30-7. PubMed ID: 12516049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
    Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
    Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexpression of the uracil phosphoribosyltransferase gene with a chimeric human nerve growth factor receptor/cytosine deaminase fusion gene, using a single retroviral vector, augments cytotoxicity of transduced human T cells exposed to 5-fluorocytosine.
    O'Brien TA; Tuong DT; Basso LM; McIvor RS; Orchard PJ
    Hum Gene Ther; 2006 May; 17(5):518-30. PubMed ID: 16716109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytosine deaminase-uracil phosphoribosyltransferase and interleukin (IL)-12 and IL-18: a multimodal anticancer interface marked by specific modulation in serum cytokines.
    Khatri A; Husaini Y; Ow K; Chapman J; Russell PJ
    Clin Cancer Res; 2009 Apr; 15(7):2323-34. PubMed ID: 19318483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene.
    Ramnaraine M; Pan W; Goblirsch M; Lynch C; Lewis V; Orchard P; Mantyh P; Clohisy DR
    Cancer Res; 2003 Oct; 63(20):6847-54. PubMed ID: 14583482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of enzyme and pathway engineering strategies for 5FC-mediated suicide gene therapy applications.
    Johnson AJ; Ardiani A; Sanchez-Bonilla M; Black ME
    Cancer Gene Ther; 2011 Aug; 18(8):533-42. PubMed ID: 21394105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced anti-tumor efficacy with multi-transgene armed mesenchymal stem cells for treating peritoneal carcinomatosis.
    Ho YK; Woo JY; Loke KM; Deng LW; Too HP
    J Transl Med; 2024 May; 22(1):463. PubMed ID: 38750559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
    Cao X; Huang X; Ju DW; Zhang W; Hamada H; Wang J
    Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase.
    Chang DY; Yoo SW; Hong Y; Kim S; Kim SJ; Yoon SH; Cho KG; Paek SH; Lee YD; Kim SS; Suh-Kim H
    Int J Cancer; 2010 Oct; 127(8):1975-83. PubMed ID: 20473873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal Stem Cell Exosome-Mediated Prodrug Gene Therapy for Cancer.
    Altaner C; Altanerova U
    Methods Mol Biol; 2019; 1895():75-85. PubMed ID: 30539530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth.
    Cavarretta IT; Altanerova V; Matuskova M; Kucerova L; Culig Z; Altaner C
    Mol Ther; 2010 Jan; 18(1):223-31. PubMed ID: 19844197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.
    Kaliberov SA; Chiz S; Kaliberova LN; Krendelchtchikova V; Della Manna D; Zhou T; Buchsbaum DJ
    Cancer Gene Ther; 2006 Feb; 13(2):203-14. PubMed ID: 16082379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy.
    Kucerova L; Altanerova V; Matuskova M; Tyciakova S; Altaner C
    Cancer Res; 2007 Jul; 67(13):6304-13. PubMed ID: 17616689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.